Genome Sequencing Market 2019:Competitive Analysis By Thermo Fisher Scientific, Illumina, Inc., QIAGEN, Eurofins Scientific, Agilent Technologies, Inc., Oxford Nanopore Technologies & Others

The data included in the genome sequencing report is mainly plotted in the form of graphs, charts and tables which makes it easy to understand facts and figures about the market. This report makes available the pertinent information about your niche and saves lot of time which may otherwise need for decision making. This global market research report also identifies, analyses, and estimates the up-and-coming trends along with major drivers, challenges and opportunities in the industry. Further, analysis of vendors, geographical regions, types, and applications has been carried out here. genome sequencing report is presented with full commitment and best possible service depending upon business requirements.

Global genome sequencing market is expected to rise to an estimated value of USD 47.97 billion by 2026 registering a substantial CAGR of 13.95% in the forecast period of 2019-2026. This rise in the market can be attributed to the rising government spending, rise in the applications of genomics and the declining sequencing costs.

Ask For Complimentary Sample PDF| Request At https://databridgemarketresearch.com/request-a-sample/?dbmr=global-genome-sequencing-market

Key Market Competitors: Global Genome Sequencing Market

Few of the major market competitors currently working in the genome sequencing market are Thermo Fisher Scientific, Illumina, Inc., QIAGEN, Eurofins Scientific, Agilent Technologies, Inc., Oxford Nanopore Technologies., F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Inc., BGI, Danaher., GENERAL ELECTRIC COMPANY, Eppendorf AG, Abbott, LI-COR, Inc., Siemens, PerkinElmer Inc., Macrogen Inc., DNASTAR, Geneious, Myriad Genetics, Inc., amongst others.

Market Drivers

Increased funding and initiative by the government to promote genome sequencing and its varied applicability in numerous projects accelerates the growth of this market
Reduction in the costs of genome sequencing further boosts the growth of this market
Growing applicability of genomes in various areas including diagnosis, animal research, agriculture, drug discovery, food and beverages etc.
With changing environment of operations and advancements in technology, several new opportunities have been created thereby leading to the entry of new players and start-ups that would foster the growth of this market

Market Restraints

Expensive and high cost of genome equipments
Lack of skilled professionals

Inquiry For Customize Report With Discount at : https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-genome-sequencing-market

Segmentation: Global Genome Sequencing Market

By Product and Services
Consumables
Systems & Software
Services
By Technology
Sequencing
Microarray
Nucleic Acid Extraction & Purification
Other Technologies
By Applications
Diagnostics
Drug Discovery & Development
Precision Medicine
Agriculture & Animal Research
Other Applications
By End User
Pediatric
Research Centers
Academic & Government Institutes
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Other End Users
By Geography
North America
South America
Europe
Asia-Pacific
Middle East and Africa

Key Developments in the Market:

In November 2018, Illumina Inc., the genome sequencing giants acquires Pacific Biosciences, a developer and manufacturer of gene sequencing. With this acquisition it would combine its own short genome/DNA sequencing with the long-read sequencing technology of Pacific Biosciences in order to maintain its dominant position in the genomes market, and continue to remain the market leader. With this, it would be able to enter into a new market especially in the areas of rare and undiagnosed diseases, thereby expanding its customer base and providing innovative solutions and services to its clients.
In June 2017, GATC Biotech AG, a leading company in genome sequencing was acquired by Eurofins, the global pioneering leader in bio-analytical testing including DNA, genome testing. With this acquisition Eurofins would expand its product portfolio and better serve its present and future clients by strengthening its genomics and genomic sequencing testing by acquiring the market leader in genomes.

Competitive Analysis: Global Genome Sequencing Market

Global genome sequencing market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of genome sequencing market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Get detailed toc @ https://databridgemarketresearch.com/toc/?dbmr=global-genome-sequencing-market

Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Corporatesales@databridgemarketresearch.com

About Data Bridge Market Research
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune. We ponder into the heterogeneous markets in accord with our clients needs and scoop out the best possible solutions and detailed information about the market trends. Data Bridge delve into the markets across Asia, North America, South America, Africa to name few.
Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

This release was published on openPR.